DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 129 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is 2.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,354,994 | +2.8% | 7,608,394 | 0.0% | 14.46% | +27.9% |
| Q2 2023 | $90,844,224 | -10.7% | 7,608,394 | 0.0% | 11.30% | -17.9% |
| Q1 2023 | $101,724,228 | -37.5% | 7,608,394 | +0.5% | 13.77% | -29.8% |
| Q4 2022 | $162,870,182 | -0.5% | 7,568,317 | -7.4% | 19.62% | +8.6% |
| Q3 2022 | $163,628,000 | +1.9% | 8,169,171 | -8.9% | 18.06% | -32.7% |
| Q2 2022 | $160,533,000 | +97.3% | 8,968,305 | +9.3% | 26.84% | +160.9% |
| Q1 2022 | $81,360,000 | -41.1% | 8,201,638 | 0.0% | 10.29% | -19.0% |
| Q4 2021 | $138,198,000 | – | 8,201,638 | – | 12.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |